Spots Global Cancer Trial Database for Extracorporal Photopheresis Pilot Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Extracorporal Photopheresis Pilot Study
Official Title: Allogenic Hematopoietic Stem Cell Transplantation (HSCT) From a Genoidentical Donor After a Reduced Intensity Conditioning Transplantation (RICT) Followed by an Early Preventive Treatment (Day 21) With Extracorporal Photopheresis After Transplantation.
Study ID: NCT00930566
Conditions
Study Description
Brief Summary: ECP will be given to the patients \[UVAR®XTS TM Therakos system, Johnson \& Johnson\] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allowed it: 2 ECP per week the first 2 weeks, and 1 ECP per week during 1 month. Total = 8 ECP after transplantation.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Centre de Santé - Etablissement Français du Sang (EFS), Lyon, , France
Hôpital Edouard Herriot, Service d'Hématologie, Lyon, , France
Contact Details
Name: Mauricette Michallet, Professor
Affiliation: Hospices Civils de Lyon
Role: PRINCIPAL_INVESTIGATOR
Name: Olivier Hequet, MD
Affiliation: Etablissement Français du Sang
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
